Skip to Main Content

Author Details

Norman E Sharpless
National Cancer Institute
1945
192
76
PMIDPaper TitleJournal TitlePublished Year
37267580The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.J Clin Oncol2023
37267580The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer.J Clin Oncol2023
35019677A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.Microbiol Spectr2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
35233580Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data.medRxiv2022
35019677A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.Microbiol Spectr2022
35561684Topical therapy for regression and melanoma prevention of congenital giant nevi.Cell2022
35233580Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data.medRxiv2022
33293334Cancer Grand Challenges: Embarking on a New Era of Discovery.Cancer Discov2021
33961782Progress and potential: The Cancer Moonshot.Cancer Cell2021
33792717Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.J Natl Cancer Inst2021
33625463Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.JAMA Intern Med2021
34052390The potential of AI in cancer care and research.Biochim Biophys Acta Rev Cancer2021
34357387Cancer as a Global Health Priority.JAMA2021
33293334Cancer Grand Challenges: Embarking on a New Era of Discovery.Cancer Discov2021
33402297Corrigendum to "Role of senescence marker p16<sup>INK4A</sup> measured in peripheral blood T-lymphocytes in predicting length of hospital stay after coronary artery bypass surgery in older adults" [Exp. Gerontol. 74 (2016) 29-36].Exp Gerontol2021
34428097Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer.JCO Clin Cancer Inform2021
33792717Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.J Natl Cancer Inst2021
33625463Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.JAMA Intern Med2021
34428097Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer.JCO Clin Cancer Inform2021
33961782Progress and potential: The Cancer Moonshot.Cancer Cell2021
34052390The potential of AI in cancer care and research.Biochim Biophys Acta Rev Cancer2021
34357387Cancer as a Global Health Priority.JAMA2021
33402297Corrigendum to "Role of senescence marker p16<sup>INK4A</sup> measured in peripheral blood T-lymphocytes in predicting length of hospital stay after coronary artery bypass surgery in older adults" [Exp. Gerontol. 74 (2016) 29-36].Exp Gerontol2021
32484461Advancing progress for patients with cancer through small business innovation research.J Clin Invest2020
32484461Advancing progress for patients with cancer through small business innovation research.J Clin Invest2020
33085859Redoubling Efforts to Help Americans Quit Smoking - Federal Initiatives to Tackle the Country's Longest-Running Epidemic.N Engl J Med2020
33354682Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection.medRxiv2020
33128870A Blueprint for Characterizing Senescence.Cell2020
32554570COVID-19 and cancer.Science2020
33085859Redoubling Efforts to Help Americans Quit Smoking - Federal Initiatives to Tackle the Country's Longest-Running Epidemic.N Engl J Med2020
33128870A Blueprint for Characterizing Senescence.Cell2020
33354682Real-world data suggest antibody positivity to SARS-CoV-2 is associated with a decreased risk of future infection.medRxiv2020
32554570COVID-19 and cancer.Science2020
30662871The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.Front Oncol2019
30683717Cells exhibiting strong <i>p16</i><sup><i>INK4a</i></sup> promoter activation in vivo display features of senescence.Proc Natl Acad Sci U S A2019
30673081Modernizing Clinical Trials for Patients With Cancer.JAMA2019
30662871The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma.Front Oncol2019
30683717Cells exhibiting strong <i>p16</i><sup><i>INK4a</i></sup> promoter activation in vivo display features of senescence.Proc Natl Acad Sci U S A2019
30673081Modernizing Clinical Trials for Patients With Cancer.JAMA2019
28923912Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma.Cancer Discov2018
28923912Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma.Cancer Discov2018
29180473New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.Cancer Res2018
29744983Expression of p16<sup>INK</sup><sup>4a</sup> is a biomarker of chondrocyte aging but does not cause osteoarthritis.Aging Cell2018
29158372Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.Oncologist2018
29101163CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.Cancer Discov2018
29744983Expression of p16<sup>INK</sup><sup>4a</sup> is a biomarker of chondrocyte aging but does not cause osteoarthritis.Aging Cell2018
29158372Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.Oncologist2018
29180473New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.Cancer Res2018
29101163CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.Cancer Discov2018
  • 1 - 50 of 384

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 1
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 1
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Andrea Viale
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Vivek Shukla
Chalmers University of Technology
Career Start Year 2000
Number of shared co-authors 0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Vera Gorbunova
University of Rochester
Career Start Year 1997
Number of shared co-authors 2
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 3
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Julien Sage
Department of Pediatrics Stanford University Stanford California USA.
Career Start Year 1993
Number of shared co-authors 5
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1991
Number of shared co-authors 0
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 2
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 1
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 5
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 9
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 20
Colin R Goding
Ludwig Institute for Cancer Research, University of Oxford
Career Start Year 1983
Number of shared co-authors 3
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 3
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 1981
Number of shared co-authors 7
David M Thomas
Garvan Institute of Medical Research
Career Start Year 1980
Number of shared co-authors 3
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 10
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 9
Alexander Kamb
Inc. 30301 Agoura Rd.
Career Start Year 1979
Number of shared co-authors 0
Chi V Dang
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 4
Stephen H Friend
University of Oxford
Career Start Year 1978
Number of shared co-authors 5
Scott M Lippman
Moores Cancer Center, university of california san diego
Career Start Year 1977
Number of shared co-authors 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 22
Frank McCormick
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 7
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Nabeel Bardeesy
Massachusetts General Hospital
Co-authored papers 15
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 14
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Co-authored papers 11
Charles M Perou
Co-authored papers 8
Matthew D Wilkerson
Uniformed Services University of the Health Sciences
Co-authored papers 6
Pasi A J??nne
Dana-Farber Cancer Institute
Co-authored papers 5
Lynda Chin
Co-authored papers 5
Lynne Penberthy
National Cancer Institute
Co-authored papers 5
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 5
Douglas R Lowy
Co-authored papers 5
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Co-authored papers 4
Gary L Johnson
Co-authored papers 4
Joseph G Ibrahim
University of North Carolina
Co-authored papers 4
Jerry Usary
Co-authored papers 4
Anthony R Kerlavage
National Cancer Institute
Co-authored papers 3
Keith L Ligon
Co-authored papers 3
Jian Jin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 3
Shawn M Gomez
Co-authored papers 3
Alan P Hoyle
Co-authored papers 3
Satish Gopal
Center for Global Health, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Co-authored papers 3
Lisa A Carey
Co-authored papers 3
Eric Verdin
Buck Institute for Research on Aging
Co-authored papers 3
Jeremy M Simon
University of North Carolina
Co-authored papers 3
Charles Lee
Co-authored papers 2
Xiaobei Zhao
University of Tennessee Health Science Center
Co-authored papers 2
Peter S Hammerman
Novartis Institutes for BioMedical Research
Co-authored papers 2
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers 2
Marcus Bosenberg
Yale School of Medicine
Co-authored papers 2
Samuel L Volchenboum
University of Chicago
Co-authored papers 2
Release 1.2